MARRONE BIO INNOVATIONS INC. Amortization of Intangible Assets
MARRONE BIO INNOVATIONS INC. reported Amortization of Intangible Assets of $585.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for the quarter ending 2022-03-31 was $585.00K, a 0.17% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for the quarter ending 2021-12-31 was $585.00K, a 0.00% change year-over-year.
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for the quarter ending 2021-09-30 was $585.00K, a 0.34% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for the quarter ending 2021-06-30 was $586.00K, a 3.14% decline year-over-year.
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for fiscal 2021 was $2.34M, a 0.26% decline from fiscal 2020.
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for fiscal 2020 was $2.35M, a 199.49% increase from fiscal 2019.
- MARRONE BIO INNOVATIONS INC. amortization of intangible assets for fiscal 2019 was $784.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2022-03-31 | $585.00K 10-Q · filed 2022-05-13 | $1.17M derived: sum of 2 quarters · filed 2022-05-13 | $1.75M derived: sum of 3 quarters · filed 2022-05-13 | $2.34M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $585.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $1.17M derived: sum of 2 quarters · filed 2022-05-09 | $1.76M derived: sum of 3 quarters · filed 2022-05-09 | $2.34M 10-K/A · filed 2022-05-09 |
| 2021-09-30 | $585.00K 10-Q · filed 2021-11-10 | $1.17M derived: sum of 2 quarters · filed 2021-11-10 | $1.76M 10-Q · filed 2021-11-10 | $2.34M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $586.00K 10-Q · filed 2021-08-16 | $1.17M 10-Q · filed 2021-08-16 | $1.76M derived: sum of 3 quarters · filed 2022-05-13 | $2.34M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $586.00K 10-Q · filed 2022-05-13 | $1.17M derived: sum of 2 quarters · filed 2022-05-13 | $1.76M derived: sum of 3 quarters · filed 2022-05-13 | $2.36M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $585.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | $1.17M derived: sum of 2 quarters · filed 2022-05-09 | $1.78M derived: sum of 3 quarters · filed 2022-05-09 | $2.35M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | $587.00K 10-Q · filed 2021-11-10 | $1.19M derived: sum of 2 quarters · filed 2021-11-10 | $1.76M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $605.00K 10-Q · filed 2021-08-16 | $1.18M 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $587.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $784.00K 10-K · filed 2021-03-23 |